Fischer Medical Ventures Ltd

AI
Fischer Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Fischer Medical Ventures Ltd

₹ 34.3 0.18%
25 Sep - close price
fischermv.com BSE: 524743 NSE: FISCHER
About

Fischer Medical Ventures Ltd, earlier known as
Fischer Chemic Ltd, leads a healthcare-technology group. It makes and services medical-imaging equipment and provides
AI-based health screening and digital-health solutions. Its MRI manufacturing plant is located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam.[1]

Key Points

Business Transformation
The company has changed from its chemicals business to medical equipment, health screening, and digital-health services.[1]

Website BSE NSE
  • Market Cap ₹ 2,396 Cr.
  • Current Price ₹ 34.3
  • High / Low ₹ 122 / 31.0
  • Stock P/E 97.9
  • Book Value ₹ 5.88
  • Dividend Yield 0.15 %
  • ROCE 11.4 %
  • ROE 8.91 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Promoter holding has increased by 0.94% over last quarter.

Cons

  • Stock is trading at 5.83 times its book value
  • Company has a low return on equity of 5.74% over last 3 years.
  • Company has high debtors of 342 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.00 20.79 10.12 39.66 11.75 49.17 23.44 86.31 101.10 97.54 81.92
0.00 18.28 10.33 39.16 11.38 46.66 19.45 70.09 79.53 101.31 70.67
Operating Profit 0.00 2.51 -0.21 0.50 0.37 2.51 3.99 16.22 21.57 -3.77 11.25
OPM % 12.07% -2.08% 1.26% 3.15% 5.10% 17.02% 18.79% 21.34% -3.87% 13.73%
0.00 0.47 0.69 0.05 0.38 0.15 7.47 2.48 1.09 0.77 1.48
Interest 0.00 0.05 0.13 0.05 0.07 0.23 0.66 0.92 0.64 3.66 3.54
Depreciation 0.00 0.18 0.28 0.29 0.56 0.51 0.77 0.51 0.77 0.93 1.36
Profit before tax 0.00 2.75 0.07 0.21 0.12 1.92 10.03 17.27 21.25 -7.59 7.83
Tax % 6.18% 271.43% -38.10% 350.00% 26.04% 51.55% 19.46% 9.18% 64.03% 51.60%
0.00 2.59 -0.12 0.29 -0.29 1.31 4.86 13.90 19.23 -12.44 3.79
EPS in Rs 0.00 0.05 -0.00 0.01 -0.01 0.02 0.07 0.21 0.30 -0.19 0.06
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
0 21 111 308 367
0 19 107 265 322
Operating Profit 0 2 3 43 45
OPM % 11% 9% 3.0% 14% 12%
0 0 1 12 6
Interest 0 0 0 6 9
Depreciation 0 0 2 3 4
Profit before tax 0 2 3 47 39
Tax % 13% 37% 33%
-0 2 1 31 24
EPS in Rs -0.24 0.03 0.02 0.49 0.38
Dividend Payout % 0% 0% 22% 1%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 1097%
TTM: 196%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 831%
TTM: 286%
Stock Price CAGR
10 Years: 69%
5 Years: 22%
3 Years: 73%
1 Year: -70%
Return on Equity
10 Years: %
5 Years: %
3 Years: 6%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.17 54 64 65
Reserves -0 28 274 320
1 2 85 107
0 4 34 179
Total Liabilities 0 86 457 671
0 15 24 32
CWIP 0 0 1 3
Investments 0 1 7 118
0 70 425 519
Total Assets 0 86 457 671

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
-7 -86 -101
-29 -125 -5
37 315 14
Net Cash Flow 1 103 -92
Free Cash Flow -8 -91 6
CFO/OP -392% -2,555% -194%

Ratios

Consolidated / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 345 398 251 342
Inventory Days 99 36 58
Days Payable 48 82 466
Cash Conversion Cycle 345 449 205 -67
Working Capital Days 324 498 42 159
ROCE % 5% 1% 11%

Insights

In beta
Mar 2024 Mar 2025
International markets served
countries ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Total employees
employees ・Standalone data
Cumulative preventive health screenings delivered
screenings
MOUs signed for PICA MRI systems at RSNA 2024
MOUs
MRI manufacturing capacity (double shift maximum)
MRI machines per year
MRI manufacturing capacity (single shift)
MRI machines per year
Schools in health screening partnership
schools
Target annual preventive health screenings
screenings per year
TB and cancer screenings in Assam
individuals screened

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

8 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Aug 2026
0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80% 61.80% 61.80% 62.15% 62.15% 63.09%
0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.55% 5.57% 4.85% 4.97% 5.48% 5.57%
0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42% 1.42% 1.36% 1.38% 1.35% 1.26%
99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.23% 31.22% 31.99% 31.51% 31.01% 30.09%
No. of Shareholders 9,0388,9769,2859,5029,68810,18010,05813,05422,92023,26923,95023,951

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Sep 2026
    Transcript
    AI Summary
    PPT
  • Sep 2026
    Transcript
    AI Summary
    PPT
  • Nov 2025
    Transcript PPT
  • Dec 2024
    Transcript
    AI Summary
    PPT